View Full Paper

Owner Consent Verified
Research Proposal 4.9

EdTech Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe

26
Pages
Harvard
Style
~ 27–40 mins
Reading Time
Energy RPA Cloud
Abstract

This research proposal investigates “EdTech Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe” using a randomized controlled trial design. Through a economic lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

EdTech Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe

ABSTRACT
EdTech Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe is unpacked across themes: change enablement, usability, ethics, and KPIs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
40 Pages 4.5
Gig Economy and Ethical Considerations among E-commerce Marketplaces — Evidence from East Africa
Esports Psychology DEI
View Paper
37 Pages 4.9
Sustainability Outcomes in Clinical Trials for Hospital Administrators: Evidence from Europe
Marketing BioMed InsurTech
View Paper
33 Pages 4.3
Blockchain for Fortune 500 Firms: Operational Excellence | A topic modeling on open datasets
Blockchain CV DEI
View Paper